Clinical Data

Amgen scores with new thyroid eye disease formulation

Pharmaphorum

Can Amgen's subcutaneous version of Tepezza inject renewed growth into the thyroid eye disease blockbuster?

Clinical Data Ophthalmology Read full story

pharminent April 7, 2026 (Last updated: April 8, 2026)

Pharmaphorum

Can Amgen’s subcutaneous version of Tepezza inject renewed growth into the thyroid eye disease blockbuster?

Clinical Data Ophthalmology Read full story